Key Takeaways:
- Solid Power reported Q2 EPS of -$0.11, beating the -$0.1224 consensus.
- Revenue came in at -$270,000, missing the $2.18 million estimate.
- The solid-state battery developer reported results on Aug. 4, 2026.
뒤로
Solid Power narrows Q2 loss to 11 cents, revenue misses
Solid Power reported a second-quarter loss of 11 cents a share, beating the 12.24-cent consensus, while revenue came in negative at $270,000.
The Louisville, Colorado-based solid-state battery developer, listed on the Nasdaq under SLDP, remains in a pre-revenue phase as it scales its sulfide-based electrolyte technology for electric-vehicle applications. The negative revenue figure reflects an adjustment in the quarter, a detail the company did not fully explain in its release.
The 1.24-cent EPS beat came despite a revenue shortfall of roughly $2.45 million against the $2.18 million consensus. Solid Power did not disclose updated guidance for the remainder of fiscal 2026, nor a year-over-year revenue comparison or its stock price reaction in the release.
Solid Power is among a handful of developers racing to commercialize solid-state batteries, a technology that promises higher energy density and faster charging than conventional lithium-ion cells. The company has partnered with automakers including BMW and Ford to develop cells for future EV platforms, competing with peers such as QuantumScape and Toyota's solid-state program.
The company's business model centers on licensing its sulfide electrolyte and cell designs to automakers and battery manufacturers rather than producing cells at scale itself. That structure means revenue recognition can be lumpy, tied to milestone payments and development agreements rather than steady product sales. The negative revenue print in the quarter highlights the volatility inherent in that model, as the company books revenue only when development milestones are met.
The narrower-than-expected loss suggests management is controlling costs as it advances its development pipeline. Investors will watch for updates on A-sample cell deliveries and any new partnership announcements in the second half of 2026, when the company is expected to provide further detail on its commercialization timeline.
This article is for informational purposes only and does not constitute investment advice.
